BetterInfo on Women's PrEP Choices and Outcomes in Malawi
Conditions
Long-acting Injectable Cabotegravir for PrEP · Oral Pre-Exposure Prophylaxis (PrEP)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Johns Hopkins Research Project Malawi, Blantyre, Malawi
Contact: Principal Investigator (Linda Nyondo-Mipando, PhD, RNM)
Study leads
Sheree Schwartz, PhD, MPH
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Linda Nyondo-Mipando, PhD, RNM
Principal Investigator
Kamuzu University of Health Sciences